Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -6.46x is 84% above its 5-year average of -41.25x, near the high end of its 5-year range (-227.40x–-1.30x).
86.76% above its 12-month average of -48.77x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -9.49x.
INTEREST COVERAGE RATIO
-6.46x
INTEREST COVERAGE RATIO AVG TTM
-48.77x
INTEREST COVERAGE RATIO AVG 3Y
-30.71x
INTEREST COVERAGE RATIO AVG 5Y
-41.25x
INTEREST COVERAGE RATIO AVG 10Y
-22.81x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+86.76%
CURRENT VS 3Y AVG
+78.96%
CURRENT VS 5Y AVG
+84.34%
CURRENT VS 10Y AVG
+71.68%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1.33%
vs the sector median at left
Myriad Genetics, Inc.
Market Cap
$404.24M
Interest Coverage Ratio
-6.46x
TTM Avg
-48.77x
3Y Avg
-30.71x
5Y Avg
-41.25x
Market Cap
$405.74M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$402.17M
Interest Coverage Ratio
-20641.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$406.58M
Interest Coverage Ratio
-404.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$397.99M
Interest Coverage Ratio
-21.38x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$396.93M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $404.24M | -6.46x | -48.77x | -30.71x | -41.25x |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $402.17M | -20641.60x | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | -404.95x | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $397.99M | -21.38x | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | N/A | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | -375.67x | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $415.98M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -13.80x | N/A | N/A | N/A |
Interest Coverage
-6.5x
Debt/Equity
0.69
Current Ratio
2.21
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -9.49x |
| 2026-03-31 | -7.49x |
| 2025-12-31 | -1.30x |
| 2025-09-30 | -6.13x |
| 2025-06-30 | -219.47x |
| 2025-03-31 | -36.25x |
| 2024-12-31 | -55.71x |
| 2024-09-30 | -25.00x |
| 2024-06-30 | -45.63x |
| 2024-03-31 | -55.80x |
| 2023-12-31 | -34.89x |
| 2023-09-30 | -60.10x |
| 2023-06-30 | -227.40x |
| 2023-03-31 | -104.40x |
| 2022-12-31 | -58.00x |
| 2022-09-30 | -56.25x |
| 2022-06-30 | -29.67x |
| 2022-03-31 | -28.44x |
| 2021-12-31 | -86.20x |
| 2021-09-30 | -72.64x |
| 2021-06-30 | -10.40x |
| 2021-03-31 | -15.57x |
| 2020-09-30 | -13.66x |
| 2020-06-30 | -22.03x |
| 2020-03-31 | -58.13x |
| 2019-12-31 | -3.52x |
| 2019-09-30 | -7.21x |
| 2019-06-30 | -1.75x |
| 2019-03-31 | 1.84x |
| 2018-12-31 | 1.79x |
| 2018-09-30 | 0.55x |
| 2018-06-30 | 9.70x |
| 2018-03-31 | 27.60x |
| 2017-12-31 | 9.00x |
| 2017-09-30 | 93.33x |
| 2017-06-30 | 14.17x |
| 2017-03-31 | 5.13x |
| 2016-12-31 | 6.54x |
| 2016-09-30 | 8.14x |
| 2015-12-31 | 452.00x |
